Pantoprazol Sun Pharma (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Sun Pharma, is a proton pump inhibitor presented as a unknown strength/unknown form for oral use. It reduces gastric acid secretion and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults. GNH USA supplies Pantoprazol Sun Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Pantoprazol Sun Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Sun Pharma is a proton pump inhibitor that acts on the gastric acid secretion pathway.

- Gastro‑oesophageal reflux disease (GERD): Improves symptoms and promotes healing of the oesophageal lining. - Erosive esophagitis: Facilitates the healing of erosions in the oesophagus. - Peptic ulcer disease: Supports healing of gastric and duodenal ulcers. - Zollinger‑Ellison syndrome : Reduces gas production by tumor ‑ induced acid hyper‑secretion. - Helicobacter pylori eradication regimen : Used as adjunct in triple therapy to enhance ulcer healing and increase treatment success . -  

The          ... ... ...  …  … ...